137 related articles for article (PubMed ID: 9569213)
1. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.
Camacho Vanegas O; Giusti B; Restrepo Fernandez CM; Abbate R; Pepe G
Thromb Haemost; 1998 Apr; 79(4):883-4. PubMed ID: 9569213
[No Abstract] [Full Text] [Related]
2. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
Rees DC; Liu YT; Cox MJ; Elliott P; Wainscoat JS
Thromb Haemost; 1997 Nov; 78(5):1357-9. PubMed ID: 9408019
[TBL] [Abstract][Full Text] [Related]
5. [The C677T mutation in the methylenetetrahydrofolate reductase gene and its association with deep vein thrombophilia in Shandong Hans].
Guo C; Guo Q; Gong Y; Chen B; Liu Q; Li J; Gao G; Zhou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):295-7. PubMed ID: 12170465
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis.
Balta G; Gürgey A
Turk J Pediatr; 1999; 41(2):197-9. PubMed ID: 10770658
[TBL] [Abstract][Full Text] [Related]
7. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
8. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
[TBL] [Abstract][Full Text] [Related]
9. Relationships between homocysteine, folate and vitamin B12 levels with the methylenetetrahydrofolate reductase polymorphism, in Indians from Western Venezuela.
Vizcaíno G; Diez-Ewald M; Herrmann FH; Schuster G; Pérez-Requejo JL
Thromb Haemost; 2001 Jan; 85(1):186-7. PubMed ID: 11204578
[No Abstract] [Full Text] [Related]
10. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
[No Abstract] [Full Text] [Related]
11. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
[TBL] [Abstract][Full Text] [Related]
12. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
Brown CA; McKinney KQ; Young KB; Norton HJ
Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
Rozen R
Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
[No Abstract] [Full Text] [Related]
14. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5).
Gris JC; Quéré I; Monpeyroux F; Mercier E; Ripart-Neveu S; Tailland ML; Hoffet M; Berlan J; Daurès JP; Marès P
Thromb Haemost; 1999 Jun; 81(6):891-9. PubMed ID: 10404763
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies--prevalence and significance.
Ames PR; Tommasino C; D'Andrea G; Iannaccone L; Brancaccio V; Margaglione M
Thromb Haemost; 1998 Jan; 79(1):46-9. PubMed ID: 9459321
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
Kuhn W; Hummel T; Woitalla D; Müller T
Neurology; 2001 Jan; 56(2):281; author reply 281-2. PubMed ID: 11271164
[No Abstract] [Full Text] [Related]
18. Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
Brattström L
Neurology; 2001 Jan; 56(2):281; author reply 281-2. PubMed ID: 11160979
[No Abstract] [Full Text] [Related]
19. Response to "genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A".
Isotalo PA; Donnelly JG
Am J Med Genet; 2002 Jun; 110(2):191-2. PubMed ID: 12116261
[No Abstract] [Full Text] [Related]
20. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
